Title : Reduction of the active-site iron by potent inhibitors of lipoxygenases.

Pub. Date : 1991 May 5

PMID : 1850741






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Using soybean lipoxygenase-1 as a model, we have shown that two classes of lipoxygenase inhibitors currently in development as potential antiinflammatory agents obtain a significant amount of their potency by reducing the lipoxygenase active-site iron from the active ferric state to the inactive ferrous state. Iron linoleate 9S-lipoxygenase-4 Glycine max
2 Using soybean lipoxygenase-1 as a model, we have shown that two classes of lipoxygenase inhibitors currently in development as potential antiinflammatory agents obtain a significant amount of their potency by reducing the lipoxygenase active-site iron from the active ferric state to the inactive ferrous state. Iron linoleate 9S-lipoxygenase-4 Glycine max
3 This brings to (at least) five the number of classes of lipoxygenase inhibitors that are capable of reducing the active-site ferric ion and suggests the generality of this approach in the rational design of lipoxygenase inhibitors. Ferric enterobactin ion linoleate 9S-lipoxygenase-4 Glycine max
4 This brings to (at least) five the number of classes of lipoxygenase inhibitors that are capable of reducing the active-site ferric ion and suggests the generality of this approach in the rational design of lipoxygenase inhibitors. Ferric enterobactin ion linoleate 9S-lipoxygenase-4 Glycine max